Company Overview of Transave, Inc.
Transave, Inc., a biotechnology company, develops inhaled pharmaceuticals for the treatment of lung diseases. The company’s liposomal technology allows the release of drug in the lung's microenvironment. Its products also include Arikace for the treatment of gram-negative lung infections and pseudomonas infections in cystic fibrosis patients; and cisplatin lipid complex for the treatment of cancers affecting the lungs. Transave, Inc. was founded in 1997 and is headquartered in Monmouth Junction, New Jersey. As of December 1, 2010, Transave, Inc. operates as a subsidiary of Insmed Incorporated.
11 Deer Park Drive
Monmouth Junction, NJ 08852
Founded in 1997
Key Executives for Transave, Inc.
Similar Private Companies By Industry
|Vicuron Pharmaceuticals, Inc.||United States|
|Araxes Pharma, LLC||United States|
|SC Liver Research Consortium LLC||United States|
|Callidus Biopharma, Inc.||United States|
|Dignify Therapeutics LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Transave, Inc., please visit www.transaveinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.